-
Joyina i-JYMed Peptide e-Pharmaconex 2025
I-JYMed Peptide iyavuya ukukumema kwi-Pharmaconex 2025, eyenzeka ngoSeptemba 1-3, 2025, kwi-Egypt International Exhibition Centre (EIEC) eCairo. Ukugubungela indawo yokubonisa i-12,000 + square metres, umcimbi uya kubamba ababonisi be-350 + kwaye kulindeleke ukuba ukhangele i-8,000 + professional ...Funda ngokugqithisileyo -
Joyina i-JYMed Peptide eCPhI Korea ngo-2025
I-JYMed Peptide inovuyo ukukumema kwi-CPhI Korea 2025, eqhubeka ukusuka nge-26-28 ka-Agasti, 2025, kwi-COEX Convention & Exhibition Centre eSeoul. Ukuthatha i-15,000 square metres, umcimbi kulindeleke ukuba ubambe ngaphezu kwe-450 umbukiso kwaye wamkele iindwendwe ezingaphezu kwe-10,000 zeengcali. Ngo-2024...Funda ngokugqithisileyo -
Joyina i-JYMed e-CPHI eMzantsi Mpuma Asia ngo-2025
Siyavuya ukujoyina iinkokheli zoshishino kwi-CPHI South East Asia 2025, okwenzeka ngoJulayi 16 ukuya kwi-18 e-MITEC e-Kuala Lumpur. Esi siganeko sithatha i-15,000 square metres kwaye siya kubonisa malunga nababonisi be-400. Ngaphezulu kwe-8,000 yeengcali ekulindeleke ukuba zizimase, kunye neesemina ezingama-60+ kunye neeforamu ...Funda ngokugqithisileyo -
CPHI Shanghai 2025
Ukususela ngomhla wama-24 ukuya kumhla wama-26 kuJuni ngo-2025, i-CPhI ye-23 yase-China yabanjwa ngempumelelo kwiZiko leMiboniso yeZizwe ngezizwe laseShanghai! UMongameli we-JYMed uMnu. Iqela lizibandakanye ngokuthe ngqo ngokupheleleyo ...Funda ngokugqithisileyo -
Dibana neJYMed kwiVeki ye-Interphex eTokyo ngo-2025
Sinochulumanco ukwazisa ukuba i-JYMed izakubonisa kwiVeki ye-Interphex eTokyo ukusuka nge-9 kaJulayi ukuya kowe-11 kaJulayi, ngo-2025, eTokyo Big Sight (Ariake). Lo msitho mkhulu udibanisa ababonisi abangaphezu kwama-90 kunye neengcali ezimalunga ne-34,000 ezivela kuwo wonke amashishini amayeza kunye nezithambiso. Njengomnye weAsia '...Funda ngokugqithisileyo -
Joyina i-JYMed e-CPHI China ngo-2025
I-CPHI China 2025 iya kwenzeka ngoJuni 24-26, 2025, kwi-Shanghai New International Expo Centre (SNIEC). Ithatha ngaphezu kwe-230,000 yeemitha zesikwele, isiganeko simiselwe ukusingatha ababonisi abangaphezu kwe-3,500 kunye nokutsala ngaphezu kwe-100,000 yeengcali zoshishino. Njengomnye wawona mkhulu kwaye unempembelelo enkulu eAsia...Funda ngokugqithisileyo -
ISISEKO SOKUVELISWA KWEPEPTIDE sika-JYMED E-HUBEI UFANELE UHLOLO lwe-FDA LWESIBINI
I-Hubei JXBio Pharmaceutical Co., Ltd., indawo yokuvelisa i-peptide ezinikeleyo ye-JYMed, igqibe ngempumelelo olunye uhlolo lwendawo yi-US Food and Drug Administration (FDA) ukususela ngoMatshi 10-14. Uhlolo, oluyinxalenye yophicotho loQinisekiso loMgangatho weChiza, luvavanye iinkqubo eziphambili ezibandakanya umgangatho, imveliso...Funda ngokugqithisileyo -
UJYMED PEPTIDE UFUMANA IZIQINISEKISO EZINTATHU
I-JYMed iphumeze inkqubo yokulawula umgangatho owomeleleyo, ifumana izatifikethi ezintathu ngokuqhubekayo ukuhambisa iimveliso kunye neenkonzo ezihlangabezana nemigangatho yehlabathi.Ukufezekiswa kwesiqinisekiso se-ISO 9001 kubonisa ukuba inkampani ineenkqubo ezichazwe kakuhle kunye nemigangatho yolawulo lwangaphakathi...Funda ngokugqithisileyo -
Dibana no-JYMED KWIMINYATHO emi-3 yehlabathi ngo-2025
Siyavuya ukujoyina i-ExpoFarma (eMexico City), IPhEB (St. Petersburg), kunye ne-In-Cosmetics Global (Amsterdam) ngo-2025. Yiza uqhagamshelane neqela lethu kwaye ujonge amathuba entsebenziswano. I-Expo Farma 2025 Imihla: Ngomhla wesi-2–4 ku-Epreli, ngo-2025 Indawo: Iziko loRhwebo lweHlabathi, kwisiXeko sase-Mexico Sibanjwe yi-Asociación...Funda ngokugqithisileyo -
I-EUROPE PATENT INIKEZELWE I-LIRAGLUTIDE SYNTHESIS
I-JYMed inikwe ilungelo elilodwa lomenzi wechiza yaseYurophu ngendlela yayo yokuyila yeLiraglutide. Esi siganeko sibonakalisa ubunkokeli obuqhubekayo kwi-peptide R&D kunye ne-IP. Le patent imele inkqubo entsha yokwenziwa kwe-liraglutide, engaqinisekisi kuphela isivuno esizinzile kodwa ikwabaluleke kakhulu ...Funda ngokugqithisileyo -
Iindaba Ezivuyisayo | I-JYMed ikhusela iifayili zeDMF kwiiMveliso eziNtsha ezintlanu e-US
Kutshanje, i-Shenzhen JYMed Technology Co., Ltd. (emva koku ebizwa ngokuba yi-"JYMed") igqibe ngempumelelo iifayili zeDrug Master File (DMF) kwiimveliso ezongezelelweyo ezintlanu kunye noLawulo lwezoKutya kunye neziyobisi lwase-US (FDA), yandisa ngakumbi ipotifoliyo yayo yemveliso. MALUNGA noJYMED JYMed yi...Funda ngokugqithisileyo -
I-JYMED ikumemela kwiPCHi 2025 eGuangzhou
I-JYMED ikumema ngokunyanisekileyo ukuba uhlanganyele nathi kuMboniso we-2025 we-PCHi Cosmetic Ingredients e-Guangzhou ukuze uphonononge iindlela zentengiso zamva nje, itekhnoloji entsha, kunye nemithetho yehlabathi. Sindwendwele eBooth 6J07! I-Guan ka-2025...Funda ngokugqithisileyo -
Iindaba Ezivuyisayo | Indawo yeMveliso yePeptide yeJYMed iFumana iSiqinisekiso seWC
Kungekudala, indawo yokuvelisa i-peptide ye-JYMed, i-Hubei Jianxiang Biopharmaceutical Co., Ltd., ifumene amaxwebhu amabini asemthethweni akhutshwe yi-Hubei Provincial Drug Administration: "I-Drug GMP Compliance Inspection Result Notification" (No. E GMP 2024-258 kunye neNombolo ye-E GMP 20024) ...Funda ngokugqithisileyo -
Iindaba Ezivuyisayo | IZiko leMveliso ye-Semaglutide ye-API enkulu kunazo zonke yaseChina idlula ukuhlolwa kwe-US FDA
Ukususela ngo-Agasti 26 ukuya ku-Agasti 30, 2024, indawo yokuvelisa i-peptide ye-JYMed, i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo uhlolo lwendawo olwenziwe yi-US Food and Drug Administration (FDA). Uhlolo lwabandakanya iindawo eziphambili ...Funda ngokugqithisileyo -
2024 i-CPHI Milan yeMiboniso yoMboniso woXhomezo
01. Umboniso waMagqabantshintshi Ngomhla we-8 ka-Okthobha, uMboniso weHlabathi we-CPHI weHlabathi liphela we-2024 waqala eMilan. Njengomnye weziganeko ezibalulekileyo zonyaka kwishishini lehlabathi loxubo-mayeza, litsale abathathi-nxaxheba abavela kumazwe angama-166 kunye nemimandla. Ngokungaphezulu...Funda ngokugqithisileyo -
Iindaba Ezivuyisayo | I-JYMed's Liraglutide API iFumana iSatifikethi seWC
Ngomhla we-12 ku-Okthobha, ngo-2024, i-JYMed's Liraglutide API yafumana isatifikethi esiBhaliweyo sokuQinisekisa (WC), esiphawula inyathelo elibalulekileyo ekuthumeleni ngempumelelo i-API kwimarike ye-EU. I-WC (iSiqinisekiso esiBhaliweyo)...Funda ngokugqithisileyo -
Iindaba ezimnandi: I-JYMed's Leuprorelin Acetate Ipasile uHlolo lokuBhaliswa kweziyobisi
Kungekudala, i-JYMed Technology Co., Ltd. yazisa ukuba i-Leuprorelin Acetate, eveliswe yi-subsidiary yayo i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo ukuhlolwa kokubhaliswa kweziyobisi. Intengiso yeZiyobisi yokuqala...Funda ngokugqithisileyo -
Sivuyisana ne-JYMed's Tirzepatide igqibezela ukufayila kwe-US-DMF
I-JYMed Technology Co., Ltd. iyavuya ukwazisa ukuba imveliso yayo, i-Tirzepatide, igqibe ngempumelelo ukubhaliswa kweFayile eyi-Drug Master (DMF) kunye ne-US FDA (Inombolo ye-DMF: 040115) kwaye ifumene i-Acknowl ye-FDA ...Funda ngokugqithisileyo -
UJYMed uya kwiPCT 2024 eShanghai
I-PCT2024 Personal Care Technology Summit & Exhibition yisiganeko esinempembelelo kakhulu kwingingqi ye-Asia-Pacific, igxininise ekutshintshisweni kwetheknoloji kunye nemiboniso kwi-industry imveliso yokhathalelo lomntu.Funda ngokugqithisileyo -
I-JYMed Peptide ikumema ukuba uzimase uMboniso weZithako zezithambiso eKorea ka-2024
Indawo: Korea International Exhibition Centre Umhla: Julayi 24-26, 2024 Ixesha: 10:00 AM - 5:00 PM Idilesi: I-COEX Exhibition Centre Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics liqela elikhokelayo lokunyamekela lobuqu kwiqela lomboniso wamazwe ngamazwe ...Funda ngokugqithisileyo
